Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | STS | P08842 | 1/20 | 0.44 |
| ▸ | YAP1 | P46937 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | NOTCH1 | P46531 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25171518 | 1.00 | GPR119 (0.48) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL25171515 | 1.00 | GPR119 (0.48) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31293137 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31588516 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31588801 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31588998 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31291046 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31588908 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL22764958 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 | |
| SCHEMBL31589057 | 0.94 | GPR119 (0.47) | GPR119DPP4MMP9STSYAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250042847-A1 | SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2025-02-06 | — | — | US | disclosed |
| EP-4428129-A1 | SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF | Tuojie Biotech (Shanghai) Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042847-A1 | SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF | SLC5A2, PAH, TGFB2 | GPR119 265/4885DPP4 35/4885MMP9 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.